Researcher

R Desmond

Tallaght University Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 1, 2026 · JOURNAL ARTICLE

Baseline cardiovascular risk assessment in patients receiving proteasome inhibitors for haematological malignancies: a tertiary referral centre experience

European Heart Journal Supplements

Single-centre retrospective audit of compliance with published ESC surveillance guidance; identifies practice gaps rather than testing an intervention, with no comparator group or efficacy endpoint.

Expert GuidanceR Desmond A O'flynn Chronic Lymphocytic Leukemia Research

Reported

Sample size216

Proportion male50%

Proportion with multiple myeloma88.9%

AUG 1, 2026 · JOURNAL ARTICLE

Hypertension development and treatment in patients with solid and haematological malignancies on anti-cancer therapy: an irish tertiary referral centre experience

European Heart Journal Supplements

Single-centre observational study describing hypertension prevalence and treatment adequacy in cancer patients; provides descriptive data but lacks comparator group and causal inference.

PreliminaryR Desmond Blood Pressure and Hypertension Studies Cancer, Lipids, and Metabolism

Reported

Sample size636

Blood pressure data completion97.1%

Hypertension prevalence59%